Clinical Trials

Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT06190899 2026-04-13

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Recruiting

54 enrolled

Phase 1/2 Active not recruiting

Genital Diseases, Male, Prostatic Diseases, Prostatic Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant

NCT03543189 2026-04-01

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

44 enrolled

Prostatic Diseases, Prostatic Neoplasms

NCT04461509 2026-03-25

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

62 enrolled 11 charts

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT07103018 2026-03-23

STRIKE-001

Phase 1 Recruiting

144 enrolled

Phase 2 Not yet recruiting

Urogenital Diseases, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT07457164 2026-03-12

A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer

40 enrolled

Urogenital Diseases, Prostatic Diseases

NCT00853710 2025-11-20

Test Semiquantitative Prostate Specific Antigen (PSA)

94 enrolled

Neoplasms, Prostatic Diseases, Prostatic Neoplasms

NCT03344757 2025-09-11

Health Gatherings - For Your Health After Cancer

188 enrolled 19 charts

Genital Diseases, Male, Genital Neoplasms, Male, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT07130708 2025-08-19

Exploring the Potential of Robotic Telesurgery in Remote Settings

Phase NA Recruiting

10 enrolled

Prostatic Diseases, Prostatic Neoplasms

NCT05574647 2025-07-24

IP7-PACIFIC

Phase NA Recruiting

3,600 enrolled

Adenocarcinoma, Neoplasms, Prostatic Diseases, Prostatic Neoplasms

NCT03490838 2025-05-13

PROter

Phase 1 Terminated

27 enrolled

Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT05902637 2025-02-25

MAPROSTATE

175 enrolled

Neoplasms, Prostatic Diseases, Prostatic Neoplasms

NCT04249947 2025-02-17

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Phase 1 Terminated

40 enrolled

GenitourinaryHead & Neck

Carcinoma, Adenoid Cystic, Genital Neoplasms, Male, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Salivary Gland Neoplasms, Urogenital Neoplasms, Carcinoma, Acinar Cell, Carcinoma, Mucoepidermoid, Prostatic Neoplasms, Castration-Resistant

NCT06496581 2024-12-20

Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)

Phase 3 Recruiting

500 enrolled

Genital Diseases, Male, Prostatic Diseases

NCT06582628 2024-12-02

TEAM PC

Phase 2 Recruiting

78 enrolled

Prostatic Diseases, Prostatic Neoplasms

NCT06706921 2024-11-27

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

Phase 4 Recruiting

15 enrolled

Phase NA Active not recruiting

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases, Prostatic Neoplasms, Castration-Resistant

NCT05682742 2024-06-03

Clinical Investigation of the da Vinci Surgical System

53 enrolled

GenitourinaryOtherThoracic

Genital Diseases, Female, Hernia, Inguinal, Hernia, Ventral, Mediastinal Neoplasms, Obesity, Morbid, Prostatic Diseases, Prostatic Neoplasms, Thymoma, Pelvic Organ Prolapse

NCT00946881 2024-02-07

Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer

Phase 1/2 Completed

30 enrolled 12 charts

Genital Diseases, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT04599218 2024-02-02

MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer

1,586 enrolled

Prostatic Diseases, Prostatic Neoplasms

NCT04656678 2024-02-02

Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer

200 enrolled

Prostatic Diseases, Prostatic Neoplasms

NCT05803096 2024-01-30

Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain

Phase 4 Completed

143 enrolled 12 charts

Anxiety Disorders, Neoplasms, Pain, Prostatic Diseases, Prostatic Hyperplasia, Prostatic Neoplasms

NCT05150236 2023-12-15

ANZUP2001

Phase 2 Unknown

93 enrolled

Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT02578797 2023-11-09

A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study

45 enrolled

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT04575766 2023-08-09

A Study of FT-7051 in Men With MCRPC

Phase 1 Terminated

25 enrolled

Urogenital Diseases, Prostatic Diseases, Prostatic Neoplasms

NCT04880681 2023-05-01

Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle

60 enrolled

Disease, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT05834270 2023-04-28

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

60 enrolled

Prostatic Diseases, Prostatic Hyperplasia, Prostatic Neoplasms

NCT04831307 2021-12-03

68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical

10 enrolled

Neoplasms, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Disease Attributes

NCT03490032 2020-11-17

PROfind

Phase 1/2 Completed

30 enrolled 30 charts

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT04225299 2020-11-13

Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer

Phase 3 Withdrawn

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT04462926 2020-09-17

PSMA-PROSTAPET

100 enrolled

Neoplasms, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Disease Attributes

NCT03077659 2019-08-20

Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer

16 enrolled 12 charts

Genital Neoplasms, Male, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT04026763 2019-07-19

MR/TRUS Fusion Guided Prostate Biopsy

520 enrolled

Prostatic Diseases

NCT01310894 2019-07-11

PCM301

Phase 3 Completed

413 enrolled

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT03104907 2018-11-29

Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer

15 enrolled

Prostatic Diseases, Prostatic Neoplasms, Urological Manifestations, Lower Urinary Tract Symptoms

NCT00672009 2018-10-24

A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer

Phase 2 Terminated

11 enrolled

Adenocarcinoma, Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT02606123 2018-03-01

Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Terminated

28 enrolled

Genital Diseases, Male, Genital Neoplasms, Male, Prostatic Diseases, Prostatic Neoplasms

NCT01316458 2017-06-01

Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy

51 enrolled

Abdominal Neoplasms, Genital Diseases, Male, Genital Neoplasms, Male, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT01431391 2017-05-30

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

68 enrolled 11 charts

Adenocarcinoma, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT00707356 2016-04-19

Study of WST11 in Patients With Localized Prostate Cancer

42 enrolled

Genital Diseases, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT01875393 2016-04-19

PCM304

Phase 3 Completed

81 enrolled

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT01307852 2016-04-06

In Vivo Dosimetry During Prostate Cancer Radiotherapy

7 enrolled

Prostatic Diseases

NCT02049190 2015-06-24

Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

Phase 1/2 Unknown

75 enrolled

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT00975429 2015-04-28

Study Using WST11 in Patients With Localized Prostate Cancer

86 enrolled

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT00753415 2015-03-17

A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

BreastDermatologicEndocrineGastrointestinalGenitourinaryNETThoracic

37 enrolled 10 charts

Adenocarcinoma, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Breast Diseases, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Genital Diseases, Male, Intestinal Neoplasms, Kidney Diseases, Kidney Neoplasms, Melanoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Prostatic Diseases, Prostatic Neoplasms, Skin Diseases, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Colorectal Neoplasms, Neuroectodermal Tumors, Nevi and Melanomas, Neuroendocrine Tumors

NCT00749502 2013-07-25

A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)

GenitourinaryGynecologicLymphoidOther hematologic neoplasm

113 enrolled

Adnexal Diseases, Endocrine System Diseases, Endocrine Gland Neoplasms, Genital Diseases, Female, Genital Diseases, Male, Genital Neoplasms, Female, Genital Neoplasms, Male, Gonadal Disorders, Neoplasms, Ovarian Diseases, Ovarian Neoplasms, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell

NCT00895466 2009-05-08

Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients

Phase 1/2 Unknown

12 enrolled